Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
about
Huntington's disease: a clinical review.Therapeutic interventions for symptomatic treatment in Huntington's diseaseVesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryEvidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of NeurologyVesicular monoamine transporter 2: role as a novel target for drug developmentTreatment of Huntington's disease.Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's DiseaseTetrabenazine: Spotlight on Drug Review.Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibitionAn International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's DiseaseEffectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineMice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease.Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbensTardive dyskinesia: therapeutic options for an increasingly common disorder.Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyTetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant YellowRandomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Therapeutic Strategies in Huntington's DiseaseTetrabenazine is neuroprotective in Huntington's disease mice.Altered cholesterol and fatty acid metabolism in Huntington diseaseUse of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study.Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?Tracking motor impairments in the progression of Huntington's disease.NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.Tetrabenazine in the treatment of Huntington's diseaseDifferential electrophysiological changes in striatal output neurons in Huntington's disease.New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2)An automated and quantitative method to evaluate progression of striatal pathology in Huntington's disease transgenic mice.Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's DiseaseNeuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.Gene therapy in mouse models of huntington disease.Effect of tetrabenazine on motor function in patients with huntington disease.Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance
P2860
Q21202876-28A96A05-7596-48B2-809A-872391E71934Q24239893-9B7C7F96-3FAE-4BEC-9968-E59343F9C916Q24601233-5DAA8202-A174-426C-8EA5-5180FDB29296Q24621818-BE9ED110-13FE-4C97-874B-D046C5918FD1Q24647764-E92A4D8C-24C8-4048-816F-A45C6D2F3824Q26782004-95857966-95C7-4A2A-A360-74A9F7DD806EQ27015687-4DB8FFF7-EF4C-48BD-A913-E0D8A55E8EBDQ27692599-D96A0346-6E56-47B6-BC2A-58DE1B9CE619Q28394979-B762DA6E-C2C8-4F15-8153-03A081F6916CQ28476791-79A094C4-F4D0-41F3-AF18-1301AE5F195CQ28538703-1375B6F3-75A9-43A5-8F73-316EE1F1677BQ28748449-B64342AC-FE4C-4F6D-B6FD-328A62C197FDQ30474047-A2C2B22E-4402-4AEA-AF3A-E2AAF4F28627Q30493813-86B65642-3204-450B-9D93-6A1CCB5D6377Q30566749-378B2A9F-672E-45BB-89F7-38B4FBA48819Q30577157-86B5A870-EADF-4A84-9161-5DB37C4E767DQ33519733-D37FFE7C-C26B-4F17-95A4-914D8931A965Q33630896-2F95309B-42B4-4E36-AF81-9DBEA44276C4Q33714619-4C9682C4-DC50-49FC-9426-8235B17A3130Q33788929-C6356263-48B6-441D-9870-65015DC1F165Q33790829-56C98AFA-5B18-44D1-94D1-D8B3059ADD11Q33863426-A01C62C2-5470-4EC8-8067-65C9DEB87DE1Q34080706-F5321537-B04D-4CBF-A543-C2856FA89E11Q34090564-68C1F8AB-A2B5-4978-8866-5C7C0069E12EQ34184185-33777EA8-6A59-4929-8CA8-C0CD7676F651Q34221351-1101789D-B94D-4B51-B4B3-39189C49E051Q34284039-0578F39E-59A1-48DC-9A77-E2575567B229Q34449476-FA959B4B-4237-4E8D-93F9-33B6E28FFE9DQ34492934-9874F69A-FC5C-4E0B-A698-B22569E49FA8Q34547558-DAEB2A0B-D409-4F95-9F15-349B5A182E65Q34606748-88C761A5-7076-4558-817D-43E9BB7F8A91Q34764514-34089AB2-D11F-44BD-9245-83238A0E6D00Q34823681-A935171D-DE8B-46A3-A07C-6A34747B4110Q35049775-0625E3DE-0330-4711-A419-46A0ABA32A72Q35055022-06E647F6-C9F5-44E3-B15C-0ADB9056C993Q35072356-D00A9A48-7454-458D-8822-4B31C4291A2DQ35090208-2F7AD0AF-ACA7-4E0C-B3DA-1E10467D1D8BQ35309355-60D7B2B1-50B1-4B44-A098-0C903430F75EQ35839434-3E3260B9-3817-4237-949C-5F072D19C038Q35906778-A30424B9-1843-4D41-AC18-22B2F89BCF18
P2860
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@en
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@nl
type
label
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@en
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@nl
prefLabel
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@en
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@nl
P1433
P1476
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
@en
P2093
Huntington Study Group
P304
P356
10.1212/01.WNL.0000198586.85250.13
P407
P577
2006-02-01T00:00:00Z